Trastuzumab
#
Find similar titles
- (rev. 3)
- Hyungyong Kim
Structured data
Trastuzumab (INN; trade names Herclon, Herceptin) is a Monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain Breast cancers.
Table of Contents
Incoming Links #
Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #
- Biomarkers in triple negative breast cancer: A review
- Comprehensive molecular portraits of human breast tumours
- Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype
- The cancer genome
Related Articles (Article 1) #
Related Books (Book 2) #
Related Drugs (Drug 3) #
Suggested Pages #
- 0.511 PIK3CA
- 0.056 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
- 0.036 ConSig
- 0.023 Cancer
- 0.022 Exome sequencing
- 0.021 Journal of Breast Disease
- 0.021 Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- 0.021 June 30
- 0.020 July 28
- 0.019 Tamoxifen
- More suggestions...